Table 1.
Similarities in muscle-invasive bladder cancer between dogs and humans |
Physiological age of onset |
Clinical signs/symptoms |
Cellular and pathological features including high grade, tumor heterogeneity, and local invasion |
Molecular subtypes (e.g. luminal, basal) |
Biological behavior (sites and frequency of metastasis) |
Response to chemotherapy (e.g. cisplatin, carboplatin, vinblastine) |
Shared molecular targets (e.g. EGFR, CDKN2B, PIK3CA, BRCA2, NFkB, ARHGEF4, XPA, RB1CC1, RPS6, MITF, and WT1) |